1. Home
  2. TRVI vs YALA Comparison

TRVI vs YALA Comparison

Compare TRVI & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • YALA
  • Stock Information
  • Founded
  • TRVI 2011
  • YALA 2016
  • Country
  • TRVI United States
  • YALA United Arab Emirates
  • Employees
  • TRVI N/A
  • YALA N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • YALA Computer Software: Programming Data Processing
  • Sector
  • TRVI Health Care
  • YALA Technology
  • Exchange
  • TRVI Nasdaq
  • YALA Nasdaq
  • Market Cap
  • TRVI 1.4B
  • YALA 1.2B
  • IPO Year
  • TRVI 2019
  • YALA 2020
  • Fundamental
  • Price
  • TRVI $10.91
  • YALA $7.39
  • Analyst Decision
  • TRVI Strong Buy
  • YALA
  • Analyst Count
  • TRVI 9
  • YALA 0
  • Target Price
  • TRVI $20.72
  • YALA N/A
  • AVG Volume (30 Days)
  • TRVI 1.6M
  • YALA 375.2K
  • Earning Date
  • TRVI 11-10-2025
  • YALA 11-10-2025
  • Dividend Yield
  • TRVI N/A
  • YALA N/A
  • EPS Growth
  • TRVI N/A
  • YALA 14.19
  • EPS
  • TRVI N/A
  • YALA 0.81
  • Revenue
  • TRVI N/A
  • YALA $348,190,638.00
  • Revenue This Year
  • TRVI N/A
  • YALA $3.95
  • Revenue Next Year
  • TRVI N/A
  • YALA $10.18
  • P/E Ratio
  • TRVI N/A
  • YALA $9.11
  • Revenue Growth
  • TRVI N/A
  • YALA 6.79
  • 52 Week Low
  • TRVI $2.36
  • YALA $3.83
  • 52 Week High
  • TRVI $11.83
  • YALA $9.29
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 55.76
  • YALA 51.89
  • Support Level
  • TRVI $10.22
  • YALA $7.30
  • Resistance Level
  • TRVI $11.82
  • YALA $7.83
  • Average True Range (ATR)
  • TRVI 0.55
  • YALA 0.22
  • MACD
  • TRVI -0.08
  • YALA 0.04
  • Stochastic Oscillator
  • TRVI 30.12
  • YALA 51.72

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About YALA Yalla Group Limited each representing one

Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.

Share on Social Networks: